HM Payson & Co’s Omega Therapeutics, Inc. Common Stock OMGA Stock Holding History

HM Payson & Co’s Portfolio OMGA Stock Details OMGA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-2,500	Closed	-$1.86K	–	1092
2024 Q4	$1.86K	Buy	+2,500	New	+$2.49K	﹤0.01%	965

Other funds holding OMGA

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Principal Securities Des Moines, Iowa $6.82B AUM 17.15% 1-Year Est. Return

SPIA

Steward Partners Investment Advisory New York $19.6B AUM 22.89% 1-Year Est. Return

HM Payson & Co's OMGA Position: Q1 2025 in Review

HM Payson & Co sold out of Omega Therapeutics, Inc. Common Stock (OMGA) in Q1 2025, closing a stake of 2,500 shares — an estimated $1.86K sold.

HM Payson & Co first reported a position in OMGA in Q4 2024 and held it in 1 quarter. The position peaked at $1.86K in Q4 2024. 4 funds tracked by Wall St. Rank hold OMGA as of Q1 2025.

HM Payson & Co reported no remaining Omega Therapeutics, Inc. Common Stock position as of Q1 2025 after selling out during the quarter.
HM Payson & Co sold 2,500 Omega Therapeutics, Inc. Common Stock shares in Q1 2025, an estimated $1.86K.
HM Payson & Co first reported a position in Omega Therapeutics, Inc. Common Stock in Q4 2024 and held it in 1 quarter.
HM Payson & Co's Omega Therapeutics, Inc. Common Stock position peaked at $1.86K in Q4 2024.
4 funds tracked by Wall St. Rank held Omega Therapeutics, Inc. Common Stock as of Q1 2025.

Based on HM Payson & Co's 13F filing for Q1 2025, filed 29 Apr 2025.